Skip Navigation LinksHome > December 2013 - Volume 19 - Issue 6, Muscle Disease > Administration of Glucocorticoids in Boys With Duchenne Musc...
CONTINUUM: Lifelong Learning in Neurology:
doi: 10.1212/01.CON.0000440667.79792.cd
Practice Issues

Administration of Glucocorticoids in Boys With Duchenne Muscular Dystrophy

Gutierrez, Amparo MD, FAAN; England, John D. MD, FAAN

Collapse Box

Abstract

Duchenne muscular dystrophy (DMD) is the most common neuromuscular disease affecting boys. Advances in their care can delay the progression of DMD-related disability and prolong survival. The administration of glucocorticoids is among these advances. Glucocorticoid therapy, however, is associated with a myriad of potential adverse effects, and treating physicians as well as patients and their family members must understand the benefit/risk ratio of glucocorticoid therapy. Although current best evidence supports the use of glucocorticoids in patients with DMD, many are not offered the option. Considerable variability in practice also exists regarding when and how these drugs should be administered.

Copyright © 2013 by the American Academy of Neurology.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Login